Akari Therapeutics Plc Files 10-Q for Q1 2025
Ticker: AKTX · Form: 10-Q · Filed: May 14, 2025 · CIK: 1541157
Sentiment: neutral
Topics: 10-Q, pharmaceutical, financials
TL;DR
AKTX 10-Q filed. Financials for Q1 2025 out.
AI Summary
Akari Therapeutics Plc filed a 10-Q for the period ending March 31, 2025. The company, formerly known as Celsus Therapeutics Plc and Morria Biopharmaceuticals PLC, is in the pharmaceutical preparations industry. Their business address is located at 22 Boston Wharf Road, Boston, MA.
Why It Matters
This filing provides an update on Akari Therapeutics' financial status and operations for the first quarter of 2025, which is crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Akari Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Period End Date (Reporting period for the 10-Q filing.)
- 2024-12-31 — Previous Year End Date (Reference point for comparative financial data.)
Key Players & Entities
- Akari Therapeutics Plc (company) — Filer
- Celsus Therapeutics Plc (company) — Former Company Name
- Morria Biopharmaceuticals PLC (company) — Former Company Name
- 20250331 (date) — Period of Report
- 20250514 (date) — Filed as of Date
- 2834 (industry_code) — Standard Industrial Classification
FAQ
What is the primary business of Akari Therapeutics Plc?
Akari Therapeutics Plc is in the Pharmaceutical Preparations industry, SIC code 2834.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
What were Akari Therapeutics Plc's former names?
Akari Therapeutics Plc was formerly known as Celsus Therapeutics Plc and Morria Biopharmaceuticals PLC.
When was this 10-Q filing submitted?
This 10-Q filing was submitted on May 14, 2025.
Where is Akari Therapeutics Plc located?
Akari Therapeutics Plc's business and mailing address is 22 Boston Wharf Road, FL 7, Boston, MA 02210.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Akari Therapeutics Plc (AKTX).